Yen J, Kramer S M
Medicinal and Analytical Chemistry, Genentech, Inc., South San Francisco, CA 94080.
J Immunother (1991). 1991 Jun;10(3):174-81. doi: 10.1097/00002371-199106000-00003.
This report describes a rapid, reproducible in vitro bioassay to quantitate the cytotoxic activity of human tumor necrosis factor-alpha using a human rather than murine cell line in the absence of metabolic inhibitors. The target cells are BT-20 (breast carcinoma) cultured at 39 degrees C in the presence of recombinant human tumor necrosis factor-alpha (rHuTNF-alpha) in 96-well microtiter plates for 2 days. Cytotoxicity is measured by the crystal violet dye uptake of the remaining viable cells. This bioassay is sensitive to 1.5 ng/ml of rHuTNF-alpha, with an assay range to 130 ng/ml. Samples spiked into human plasma are measurable from 0.5 to 150 ng/ml. The specificity of this cytotoxic effect on the BT-20 cell line was demonstrated using rHuTNF-alpha neutralizing antibodies. A panel of cytokines including interferons, interleukins, and tumor necrosis factors was also analyzed using this assay system. Of the cytokines assayed, only recombinant murine tumor necrosis factor-alpha and recombinant human tumor necrosis factor-beta demonstrated measurable cytotoxic activity when assayed independently, while recombinant human interferon-gamma was the only cytokine to demonstrate greater than additive activity in combination with rHuTNF-alpha. The simplicity and reproducibility of this assay on a human cell line makes it useful for the routine determination of the biological activity of human tumor necrosis factor-alpha.
本报告描述了一种快速、可重复的体外生物测定法,用于在不存在代谢抑制剂的情况下,使用人源而非鼠源细胞系定量人肿瘤坏死因子-α的细胞毒性活性。靶细胞为BT-20(乳腺癌)细胞,在96孔微量滴定板中于39℃、含有重组人肿瘤坏死因子-α(rHuTNF-α)的条件下培养2天。通过剩余活细胞对结晶紫染料的摄取来测量细胞毒性。该生物测定法对1.5 ng/ml的rHuTNF-α敏感,测定范围为130 ng/ml。添加到人体血浆中的样品在0.5至150 ng/ml范围内可测量。使用rHuTNF-α中和抗体证明了这种对BT-20细胞系的细胞毒性作用的特异性。还使用该测定系统分析了一组包括干扰素、白细胞介素和肿瘤坏死因子在内的细胞因子。在所测定的细胞因子中,单独测定时只有重组鼠肿瘤坏死因子-α和重组人肿瘤坏死因子-β表现出可测量的细胞毒性活性,而重组人干扰素-γ是唯一与rHuTNF-α联合使用时表现出大于加性活性的细胞因子。这种在人源细胞系上进行的测定法的简单性和可重复性使其可用于常规测定人肿瘤坏死因子-α的生物活性。